HERCULES, CA--Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it ...
Bio-Rad Laboratories said it is acquiring AbD Serotec from parent company MorphoSys for €53 million ($69.7 million). The deal adds Serotec’s more than 15,000 antibodies, kits, and accessories to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results